Foghorn Therapeutics Stock Price on December 31, 2023

FHTX Stock  USD 7.90  0.06  0.77%   
If you're considering investing in Foghorn Stock, it is important to understand the factors that can impact its price. As of today, the current price of Foghorn Therapeutics stands at 7.90, as last reported on the 25th of November, with the highest price reaching 8.43 and the lowest price hitting 7.89 during the day. At this stage we consider Foghorn Stock to be slightly risky. Foghorn Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0236, which denotes the company had a 0.0236% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Foghorn Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Foghorn Therapeutics' Coefficient Of Variation of 2653.16, mean deviation of 4.06, and Downside Deviation of 4.52 to check if the risk estimate we provide is consistent with the expected return of 0.13%.
  
Total Stockholder Equity is likely to rise to about (73.3 M) in 2024. Common Stock Shares Outstanding is likely to drop to about 39.2 M in 2024. Price Earnings To Growth Ratio is likely to rise to 0.27 in 2024, whereas Price To Sales Ratio is likely to drop 7.53 in 2024. Foghorn Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0236

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskFHTXHuge Risk
Negative Returns

Estimated Market Risk

 5.39
  actual daily
47
53% of assets are more volatile

Expected Return

 0.13
  actual daily
2
98% of assets have higher returns

Risk-Adjusted Return

 0.02
  actual daily
1
99% of assets perform better
Based on monthly moving average Foghorn Therapeutics is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Foghorn Therapeutics by adding it to a well-diversified portfolio.
Price Book
10.707
Enterprise Value Ebitda
(1.21)
Price Sales
17.0821
Shares Float
26.1 M
Wall Street Target Price
16

Related Headline

HCW Biologics Headline on 29th of December 2023

Do Traders Think Hcw Biologics Inc Can Turn Around Friday InvestorsObserver

Foghorn Therapeutics Valuation on December 31, 2023

It is possible to determine the worth of Foghorn Therapeutics on a given historical date. On December 31, 2023 Foghorn was worth 6.79 at the beginning of the trading date compared to the closed value of 6.45. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Foghorn Therapeutics stock. Still, in general, we apply an absolute valuation method to find Foghorn Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Foghorn Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Foghorn Therapeutics' related companies.
 Open High Low Close Volume
  6.61    6.77    6.52    6.76    51,400  
12/29/2023
  6.79    6.79    6.34    6.45    47,000  
  6.36    6.70    6.12    6.45    120,600  
Backtest Foghorn Therapeutics  |  Foghorn Therapeutics History  |  Foghorn Therapeutics Valuation   PreviousNext  
Open Value
6.79
6.45
Closing Value
22.96
Upside

Foghorn Therapeutics Trading Date Momentum on December 31, 2023

On January 02 2024 Foghorn Therapeutics was traded for  6.45  at the closing time. The top price for the day was 6.70  and the lowest listed price was  6.12 . The trading volume for the day was 120.6 K. The trading history from January 2, 2024 did not affect price variability. The overall trading delta against the current closing price is 12.25% .

Foghorn Therapeutics Fundamentals Correlations and Trends

By evaluating Foghorn Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Foghorn Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Foghorn financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Foghorn Therapeutics Stock history

Foghorn Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Foghorn is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Foghorn Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Foghorn Therapeutics stock prices may prove useful in developing a viable investing in Foghorn Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding42 M39.2 M
Net Loss-98 M-102.9 M

Foghorn Therapeutics Stock Technical Analysis

Foghorn Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Foghorn Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Foghorn Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Foghorn Therapeutics Period Price Range

Low
November 25, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Foghorn Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Foghorn Therapeutics November 25, 2024 Market Strength

Market strength indicators help investors to evaluate how Foghorn Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Foghorn Therapeutics shares will generate the highest return on investment. By undertsting and applying Foghorn Therapeutics stock market strength indicators, traders can identify Foghorn Therapeutics entry and exit signals to maximize returns

Foghorn Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Foghorn Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Foghorn Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Foghorn to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Foghorn Stock Analysis

When running Foghorn Therapeutics' price analysis, check to measure Foghorn Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foghorn Therapeutics is operating at the current time. Most of Foghorn Therapeutics' value examination focuses on studying past and present price action to predict the probability of Foghorn Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foghorn Therapeutics' price. Additionally, you may evaluate how the addition of Foghorn Therapeutics to your portfolios can decrease your overall portfolio volatility.